US Stock MarketDetailed Quotes

HLOSF HEALIOS KK

Watchlist
  • 1.350
  • 0.0000.00%
15min DelayClose Dec 2 16:00 ET
121.68MMarket Cap-3.10P/E (TTM)

About HEALIOS KK Company

Healios KK engages in the research, development, and sale of cellular and regenerative medicine. It develops therapies for ischemic stroke, acute respiratory distress syndrome, liver disease, and age-regulated macular degeneration. The company was founded by Tadahisa Kagimoto on February 24, 2011 and is headquartered in Tokyo, Japan.

Company Profile

SymbolHLOSF
Company NameHEALIOS KK
Founded2011
CEODr. Hardy TS Kagimoto, M.D.
MarketPink Market
Employees108
Fiscal Year Ends12-31
Address1-7-1 Yurakucho,Chiyoda-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code100-0006
Phone81-3-5777-8308

Company Executives

  • Name
  • Position
  • Salary
  • Tadanao Kagimoto
  • Director
  • --
  • Richard P. Kincaid
  • Director
  • --
  • Michihisa Nishiyama
  • Director
  • --
  • Seigo Kashii
  • Independent Director
  • --
  • Glenn Gormley
  • Independent Director
  • --
  • Yuko Yogo
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data